Weihai Baihe Biology Technological Co. Ltd.
Weihai Baihe Biology Technological Co., Ltd., together with its subsidiary, Weihai Lily Functional Food Technology Research Institute Limited Company, research, develops, manufactures, and sells nutrition and health food in China and internationally. The company offers health food; nutritious food for feminine glamour, male energy, elderly care, pregnancy, babies, and childcare, as well as nutrit… Read more
Weihai Baihe Biology Technological Co. Ltd. (603102) - Total Assets
Latest total assets as of June 2025: CN¥1.87 Billion CNY
Based on the latest financial reports, Weihai Baihe Biology Technological Co. Ltd. (603102) holds total assets worth CN¥1.87 Billion CNY as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Weihai Baihe Biology Technological Co. Ltd. - Total Assets Trend (2019–2024)
This chart illustrates how Weihai Baihe Biology Technological Co. Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Weihai Baihe Biology Technological Co. Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Weihai Baihe Biology Technological Co. Ltd.'s total assets of CN¥1.87 Billion consist of 74.6% current assets and 25.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 62.5% |
| Accounts Receivable | CN¥59.14 Million | 3.3% |
| Inventory | CN¥115.12 Million | 6.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥49.30 Million | 2.7% |
| Goodwill | CN¥517.84K | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Weihai Baihe Biology Technological Co. Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Weihai Baihe Biology Technological Co. Ltd.'s current assets represent 74.6% of total assets in 2024, an increase from 64.6% in 2019.
- Cash Position: Cash and equivalents constituted 62.5% of total assets in 2024, up from 47.1% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 3.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 6.3% of total assets.
Weihai Baihe Biology Technological Co. Ltd. Competitors by Total Assets
Key competitors of Weihai Baihe Biology Technological Co. Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
|
Maniker F & G Co. Ltd
KQ:195500
|
Korea | ₩123.42 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
|
Xinjiang Chalkis Co Ltd
SHE:000972
|
China | CN¥1.25 Billion |
|
Daehan Flour Mills Co Ltd
KO:001130
|
Korea | ₩1.61 Trillion |
Weihai Baihe Biology Technological Co. Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Weihai Baihe Biology Technological Co. Ltd. generates 0.44x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Weihai Baihe Biology Technological Co. Ltd. generates $7.67 in net profit.
Weihai Baihe Biology Technological Co. Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.97 | 7.19 | 7.47 |
| Quick Ratio | 7.34 | 6.58 | 6.76 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.22 Billion | CN¥ 1.13 Billion | CN¥ 1.02 Billion |
Weihai Baihe Biology Technological Co. Ltd. - Advanced Valuation Insights
This section examines the relationship between Weihai Baihe Biology Technological Co. Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.75 |
| Latest Market Cap to Assets Ratio | 0.08 |
| Asset Growth Rate (YoY) | 4.6% |
| Total Assets | CN¥1.82 Billion |
| Market Capitalization | $148.11 Million USD |
Valuation Analysis
Below Book Valuation: The market values Weihai Baihe Biology Technological Co. Ltd.'s assets below their book value (0.08 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Weihai Baihe Biology Technological Co. Ltd.'s assets grew by 4.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Weihai Baihe Biology Technological Co. Ltd. (2019–2024)
The table below shows the annual total assets of Weihai Baihe Biology Technological Co. Ltd. from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.82 Billion | +4.58% |
| 2023-12-31 | CN¥1.74 Billion | +4.46% |
| 2022-12-31 | CN¥1.66 Billion | +81.46% |
| 2021-12-31 | CN¥915.92 Million | +25.29% |
| 2020-12-31 | CN¥731.02 Million | +17.87% |
| 2019-12-31 | CN¥620.18 Million | -- |